December 04, 2017
2 min watch
Save
VIDEO: Comparison of large trials shows similar results with anti-VEGFs for CRVO, BRVO
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Practice Management in Rheumatology.
Added to email alerts
You've successfully added Practice Management in Rheumatology to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Practice Management in Rheumatology to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Theodore Leng, MD, discusses a poster presentation reviewing the treatment of branch retinal vein occlusion and central retinal vein occlusion among the three anti-VEGF agents at 6 months. The study showed similar treatment outcomes for bevacizumab, ranibizumab and aflibercept.
Read more from American Academy of Ophthalmology Meeting
View allJanuary 16, 2025
12 min watch
Save
January 14, 2025
2 min watch
Save
January 14, 2025
1 min watch
Save
January 10, 2025
2 min watch
Save
December 31, 2024
3 min watch
Save
December 31, 2024
6 min watch
Save
December 30, 2024
3 min watch
Save
December 29, 2024
1 min watch
Save
December 27, 2024
3 min watch
Save
Add topic to email alerts
Please provide your email address to receive an email when new articles are posted on Practice Management in Rheumatology.
Added to email alerts
You've successfully added Practice Management in Rheumatology to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
You've successfully added Practice Management in Rheumatology to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.